42 studies found for:    Myasthenia Gravis
Show Display Options
Rank Status Study
21 Recruiting The Evaluation of Belimumab in Myasthenia Gravis (MG)
Condition: Myasthaenia Gravis
Interventions: Biological: Belimumab;   Other: Placebo
22 Not yet recruiting Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: HIZENTRA ®
23 Completed FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients
Condition: Myasthenia Gravis
Interventions: Drug: tacrolimus;   Drug: placebo
24 Terminated Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Drug: Placebo;   Drug: 250 mg CK-2017357;   Drug: 500 mg CK-2017357
25 Completed A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Condition: Myasthenia Gravis, Generalized
Interventions: Drug: mycophenolate mofetil (CellCept);   Drug: placebo
26 Completed A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.
Condition: Myasthenia Gravis Generalised
Interventions: Drug: mycophenolate mofetil [CellCept];   Drug: Placebo
27 Unknown  Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: immune globulin
28 Recruiting The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy
Condition: Myasthenia Gravis
Interventions: Drug: Azathioprine;   Drug: Leflunomide
29 Recruiting Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders
Conditions: Amyotrophic Lateral Sclerosis (ALS);   Myasthenia Gravis;   Myopathies;   Stroke;   Parkinson's Disease
Intervention:
30 Recruiting Therapeutic Plasma Exchange in MG
Condition: Myasthenia Gravis
Interventions: Other: Skin biopsy;   Other: Single Fiber Electromyography
31 Terminated Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Condition: Ocular Myasthenia Gravis
Interventions: Drug: Prednisone;   Drug: Placebo
32 Completed An Open Study for Steroid Resistant, Non-Thymectomized MG Patients
Condition: Myasthenia Gravis
Intervention: Drug: tacrolimus
33 Active, not recruiting Serum Auto-Antibodies
Conditions: Multiple Sclerosis;   Myasthenia Gravis;   Transverse Myelitis
Intervention: Other: Blood Draw
34 Not yet recruiting Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)
Conditions: Myasthenia Gravis;   Systemic Lupus Erythematosus;   Rheumatoid Arthritis
Intervention: Drug: Bortezomib
35 Enrolling by invitation Study of an Intervention to Improve Problem List Accuracy and Use
Conditions: Attention Deficit Disorder With Hyperactivity;   Asthma;   COPD;   Breast Cancer;   Coronary Artery Disease;   Congestive Heart Failure;   Diabetes;   Glaucoma;   Hemophilia;   Hypertension;   Hyperthyroidism;   Hypothyroidism;   Myasthenia Gravis;   Osteoporosis;   Osteopenia;   Renal Failure;   Renal Insufficiency;   Sickle Cell Disease;   Stroke
Intervention: Other: MAPLE
36 Not yet recruiting Perception and Multisensory Integration in Neurological Patients Using fMRI
Conditions: Acute Inflammatory Demyelinating Polyradiculoneuropathy;   Myasthenia Gravis;   Stroke;   Anosognosia;   Asomatognosia
Intervention: Device: Siemens magnetom avanto1.5 Tesla, Siemens magnetom trio A Tim system 3 Tesla
37 Available Treatment Use of 3,4-Diaminopyridine
Conditions: Lambert Eaton Myasthenic Syndrome (LEMS);   Myasthenic Syndromes, Congenital
Intervention: Drug: 3,4-diaminopyridine
38 Active, not recruiting A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)
Condition: Lambert Eaton Myasthenic Syndrome
Interventions: Drug: Amifampridine Phosphate;   Drug: Placebo
39 Unknown  The Effect of Erythromycin on Occurrence of Leaks From Cervical Esophageal-Gastric Anastomosis After Trans-Hiatal Esophagectomy
Conditions: Esophagectomy;   Postoperative Complications
Intervention: Drug: intravenous (IV) administration of erythromycin
40 Unknown  Inherited Myokymia: A Clinical and Genetic Study of a Family
Condition: A Study of Clinical and Genetic Mutations in a Family of Neuromyotonia, so Called Isaac's Syndrome
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results
Indicates status has not been verified in more than two years